Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q2 2020 13F Holders as of 30 Jun 2020

Holder snapshot 7 signals
Share change
+2,442,866
Put/Call ratio
49%
SEC-reported price per share
$18.94
Number of holders
155
Value change
+$45,201,421
Number of buys
108
Open additional details 1 more signal available
Number of sells
53
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,658,403

Security key

48576U106

Report period

Q2 2020

Institutions

155

Top holders

10

Ownership snapshot

Top reported holders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Consonance Capital Manage...
Disclosed value leader
Consonance Capital Manage...
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F Lead comparable stake: 32% Showing 1-6 of 15 holder rows.

Quick read

Consonance Capital Management LP leads the comparable SEC ownership view at 32%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Consonance Capital Management LP's linked filing trail.
Comparable ownership Top 5
Consonance Capital Management LP 32%
Avoro Capital Advisors LLC 31%
BlackRock Finance, Inc. 24%
Palo Alto Investors LP 19%
ADAGE CAPITAL PARTNERS GP, L.L.C. 16%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Consonance Capital Management LP
13F
Company
13F
32%
$137,941,000
7,180,700 shares
31 Mar 2020
Avoro Capital Advisors LLC
13F
Company
13F
31%
$134,470,000
7,000,000 shares
31 Mar 2020
BlackRock Finance, Inc.
13F
Company
13F
24%
$102,313,000
5,326,002 shares
31 Mar 2020
Palo Alto Investors LP
13F
Company
13F
19%
$82,601,000
4,299,901 shares
31 Mar 2020
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
16%
$71,529,000
3,723,532 shares
31 Mar 2020
JANUS HENDERSON GROUP PLC
13F
Company
13F
14%
$62,487,000
3,252,828 shares
31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
155
Shares
69,738,739
Rows available
155
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
135
Q2 2020 holders
155
Holder diff
20
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .